|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07C 231/18 | |
| C07C 233/58 | |||
| C07C 237/20 |
| (11) | Patento numeris | 2391599 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10701538.0 |
| Europos patento paraiškos padavimo data | 2010-01-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-12-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-04-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2010/051045 |
| Data | 2010-01-29 |
| (87) | Numeris | WO 2010/086394 |
| Data | 2010-08-05 |
| (30) | Numeris | Data | Šalis |
| 0950552 | 2009-01-29 | FR |
| (72) |
NICOLAS, Marc, FR
HELLIER, Paul, FR
DIARD, Catherine, FR
SUBRA, Laurent, FR
|
| (73) |
Pierre Fabre Médicament,
45, Place Abel Gance, 92100 Boulogne-Billancourt,
FR
|
| (54) | METHOD FOR SYNTHESIS OF (1S, 2R)-MILNACIPRAN |
| METHOD FOR SYNTHESIS OF (1S, 2R)-MILNACIPRAN |